NCT03315520 2018-05-22
BeEAC-1
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Phase 2 Unknown
Clinical Trials
6 trialsNCT02836639 2016-07-19
BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma
Pusan National University Hospital
Phase 2 Unknown
NCT02134262 2014-11-06
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
Jichi Medical University
Phase 1/2 Unknown
NCT01570049 2012-08-02
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma
Shandong Lanjin Pharmaceuticals Co.,Ltd
Phase 3 Unknown
NCT01221103 2011-09-13
Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)
Southern Europe New Drug Organization
Phase 1/2 Unknown
NCT00385125 2006-10-06
Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL
University of Magdeburg
Phase 2 Unknown